The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect

Medicine & Life Sciences

• 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one 100%
• Ataxia Telangiectasia 70%
• Urinary Bladder Neoplasms 53%
• Ionizing Radiation 31%
• Proteins 20%
• Phosphorylation 12%
• Catalytic DNA 9%
• DNA-Activated Protein Kinase 8%
• Kinetics 8%
• Radiation Tolerance 7%
• Double-Stranded DNA Breaks 7%
• Tumor Suppressor Genes 6%
• S Phase 6%
• DNA Repair 5%
• Ovarian Neoplasms 5%
• Catalytic Domain 5%
• DNA Damage 5%
• Fluorescent Antibody Technique 5%
• Small Interfering RNA 5%
• Cell Cycle 4%
• Flow Cytometry 4%
• Radiotherapy 4%
• Western Blotting 4%
• Phenotype 3%
• Cell Line 3%
• DNA 3%
• Survival 3%
• Therapeutics 1%